Marinus Pharmaceuticals: Q2 Earnings Snapshot

Audio By Carbonatix

RADNOR, Pa. (AP) _ Marinus Pharmaceuticals Inc. (MRNS) on Thursday reported a loss of $39.4 million in its second quarter.

On a per-share basis, the Radnor, Pennsylvania-based company said it had a loss of $1.06.

The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 93 cents per share.

The epilepsy drug developer posted revenue of $1.8 million in the period, also missing Street forecasts. Five analysts surveyed by Zacks expected $2.3 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MRNS at https://www.zacks.com/ap/MRNS